DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 3Egis Pharmaceuticals PLC
03 1Olpha
04 3NanoAlvand
05 2Aizant Drug Research Solutions Pvt. Ltd.
06 2Aurobindo Pharma Limited
07 3Bluepharma
08 3Cipla Medpro South Africa
09 3MSN Laboratories
10 1NANO DARU
11 3Pfizer Consumer Healthcare
12 21Pfizer Inc
13 3Pluviaendo
14 3Sun Pharmaceutical Industries Limited
15 3Synthon Pharmaceuticals
16 3Tecnimede
17 1TherDose Pharma
18 3XYZ Pharma
01 6CAP
02 3CAPSULE; ORAL
03 13CAPSULE;ORAL
04 3Caps
05 10Capsule
06 3Capsule, hard
07 3Film Coated Tablet
08 3Filmtabl
09 3Hard Capsules
10 3Hard Gelatin Capsule
11 3Oral Solid Dosage Form
12 3TABLET
13 6TABLET;ORAL
14 1Tablet
15 1Tablets
16 3Blank
01 1Dossier Readiness: Q3 2025
02 3Generic
03 3Lead Market Dossiers- Filed
04 3Lead Market Dossiers- Tentative\nApproved in US
05 3Originator
06 3Prescription
07 9RX
08 42Blank
01 3Cybrin
02 9IBRANCE
03 12Ibrance
04 16PALBOCICLIB
05 1Palbociclib 100 mg Cipla
06 1Palbociclib 125 mg Cipla
07 1Palbociclib 75 mg Cipla
08 1Palbociclib Pfizer 100 mg
09 1Palbociclib Pfizer 125 mg
10 1Palbociclib Pfizer 75 mg
11 21Blank
01 3Australia
02 3Canada
03 3Hungary
04 7India
05 4Iran
06 1Latvia
07 3Norway
08 6Portugal
09 6South Africa
10 6Switzerland
11 3Turkey
12 22USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Regulatory Info :
Registration Country : Hungary
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Hungary
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Regulatory Info :
Registration Country : Hungary
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Hungary
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Regulatory Info :
Registration Country : Hungary
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Hungary
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213152
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213152
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number : 214758
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE; ORAL
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number : 213107
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE; ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213107
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE; ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213107
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA
LOOKING FOR A SUPPLIER?